Mouse PD-L1 / B7-H1 Protein
Specifications | |
---|---|
Category: | Immune Checkpoint Proteins |
Molecular Weight: | 26.6 kDa |
Tag: | C-10×His |
Label / Conjugate: | N/A |
Source: | Mouse PD-L1, His Tag (PD1-M5220) is expressed from human 293 cells (HEK293). It contains AA Phe 19 - Thr 238 (Accession # NP_068693). |
Purity: | 95% |
Endotoxin Level: | 1.0 EU per μg |
Format: | Powder |
Additional Information | |
---|---|
Synonyms: | PD-L1,CD274,B7-H1,PDCD1L1,PDCD1LG1 |
Organism: | Mouse |
Accn. No.: | NP_068693 |
Sequence Information
Phe 19 - Thr 238
Background
Programmed cell death 1 ligand 1 (PDL1) is also known as B7-H, B7H1, MGC142294, MGC142296, PD-L1, PDCD1L1 and PDCD1LG1,which is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses.PDL1 is a cell surface immunoglobulin superfamily with two Ig-like domains within the extracellular region and a short cytoplasmic domain. This protein is broadly expressed in the majority of peripheral tissues as well as hematopoietic cells. Interaction between PDL1 and its receptors belonging to the CD28 family of molecules provide both stimulatory and inhibitory signals in regulating T cell activation and tolerance. PDL1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression.
Product Citations
- X Qian, T Fei, Z LI (2019) Novel anti-PD-1 antibodies US20190330348A1
- Z Lin, Y Zhang, H Cai, F Zhou, H Gao, L Deng, R Li (2019) PD-L1-based cancer vaccine elicits antitumor immunity in a mouse melanoma model Molecular Therapy: Oncolytics
- Wang, Aijun (Camarillo, CA, US) Shanebeck, Kurt (Camarillo, CA, US) He, Donggou (Camarillo, CA, US) Yao, Chen (Moorpark, CA, US) Li, Lu (Camarillo, CA, US) Xia, Fang (Camarillo, CA, US) Lu, Yuefeng (Newbury Park, CA, US) Lu, Jian-feng (Oak Park, CA, US) Yang, Lan (Camarillo, CA, US) (2017) PD-L1 specific monoclonal antibodies for disease treatment and diagnosis US20170355770A1
Price
2.666,00 €